Log in to save to my catalogue

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237629

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

About this item

Full title

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2018-11, Vol.563 (7731), p.360-364

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of potent HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) administered when antiretroviral therapy (ART) was discontinued, but it remains unclear whether bNAbs can target the viral re...

Alternative Titles

Full title

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237629

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237629

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-018-0600-6

How to access this item